Lamotrigine in the treatment of bipolar disorder

REFERENCES

• NEMEROFF CB: An ever-increasing pharmacopeia for the management of patients with bipolar disorder. I. Clin. Psychiatr. (2002) 61 (Suppl. 13):19–25.
   Google Scholar
• COHN JB, COLLINS G, ASHBROOK E, WERNICKE JF: A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder. Int. Clin. Psychopharmacol (1989) 4:313–322.
   PubMed Web of Science ®Google Scholar
• SACHS GS, PRINTZ DJ, KAHN DA, CARPENTER D, DOCHERTY JP: The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder McGraw-Hill Companies (2000):1–108.
   Google Scholar
• HIMMELHOCH JM, FUCHS CZ, SYMONS BJ: A double-blind study of tranylcypomine treatment of major anergic depression. Nerv. Ment. Dis. (1982) 170:628–634.
   PubMedGoogle Scholar
• PRIEN RE KLETT CJ, CAFFEY EM: Lithium carbonate and imipramine in prevention of affective episodes. Arch. Gen. Psychiatr. (1973) 29:420–425.
   PubMedGoogle Scholar
• QUITKIN FM, KANE J, RIFKIN A, RAMOS-LORENZI JR, NAYAK DV: Prophylactic lithium carbonate with and without imipramine for bipolar I patients: A double-blind study. Arch. Gen. Psychiatr. (1981) 38:902–907.
   PubMed Web of Science ®Google Scholar
• SMITH D, BAKER G, DAVIES G, DEWEY M, CHADWICK DW: Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia (1993) 34:312–322.
   PubMed Web of Science ®Google Scholar
• MESSENHEIMERJ, MULLENS EL, GIORGI L, YOUNG F: Safety of adult clinical trial experience with lamotrigine. Drug Safety (1998) 18:281–296.
   PubMed Web of Science ®Google Scholar
• LEES G, LEACH MJ: Studies on the mechanism of action of the novel anticonvulsant lamotrigine (lamictal) using primary neuroglial cultures from rat cortex. Brain Res. (1993) 612:190–199.
   PubMed Web of Science ®Google Scholar
• MCGEER EG, ZHU SG: Lamotrigine protects against kainate but not ibotenate lesions in rat striatum. Neurosci. Lett. (1990) 112:348–351.
   PubMed Web of Science ®Google Scholar
• LEACH MJ, MARDEN CM, MILLER AA: Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia (1986) 27:490–497.
   PubMed Web of Science ®Google Scholar
• BAUKROWITZ T, YELLEN G: Use-dependent blockers and exit rate of the last ion from the multi-ion pore of a K+ channel. Science (1996) 271:653–656.
   PubMedGoogle Scholar
• CALABRESE JR, BOWDEN CL, MCELROY SL et al: Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder. Am. .1 Psychiatr. (1999) 156:1019–1023.
   PubMed Web of Science ®Google Scholar
• BOWDEN CL, CALABRESE JR, MCELROY SL et al: The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder. Biol. Psychiatr. (1999) 45:953–958.
   PubMed Web of Science ®Google Scholar
• CALABRESE JR, FATEMI SH, WOYSHVILLE MJ: Antidepressant effects of lamotrigine in bipolar rapid cycling. Am. Psychiatr. (1996) 153:1236.
   PubMed Web of Science ®Google Scholar
• CALABRESE JR, BOWDEN CL, SACHS GS, ASCHER JA, MONAGHAN E, RUDD DG: A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Clin. Psychiatr. (1999) 60:79–88.
   PubMed Web of Science ®Google Scholar
• BOWDEN CL, MITCHELL P, SUPPES T:Lamotrigine in the treatment of biopolar depression. Eur. Neuropsychopharmacol (1999) 9\(Suppl. 4):5113–5117.
   Google Scholar
• MONTGOMERY SA, ASBERG M: A new depression scale designed to be sensitive to change. Brj Psychiatr. (1979) 134:382–389.
   PubMed Web of Science ®Google Scholar
• FRYE MA, KETTER TA, KIMBRELL TA et al: A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J. Clin. Psychopharmacol. (2000) 20:607–614.
   PubMed Web of Science ®Google Scholar
• ASCHER J, BARNETT S, BATEY S: Safety and tolerability of lamotrigine in controlled mood disorder trials. 2001 Annual Meeting of the American Psychiatric Association New Orleans, LA, USA (5–10 May 2001).
   Google Scholar
• BOWDEN CL, CALABRESE JR, SACHS G et al: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch. Gen. Psychiatr. (2002) In press.
   Google Scholar
• BOWDEN CL, GHAEMI N, GYULAI L et al: Lamotrigine delays mood episodes in recently depressed bipolar I patients. New research. 155th American Psychiatric Association Annual Meeting. Philadelphia, PA, USA (18–23 May 2002).
   Google Scholar
• PRIEN RF, CAFFEY EM, KLETT CJ. Prophylactic efficacy of lithium carbonate in manic-depressive illness. Arch. Gen. Psychiatr. (1973) 28:337–341.
   PubMed Web of Science ®Google Scholar
• PRIEN RF, KLETT CJ, CAFFEY EM JR: Lithium prophylaxis in recurrent affective illness. Am. Psychiatr. (1974)131:198–202.
   PubMed Web of Science ®Google Scholar
• CALABRESE JR, SUPPES T, BOWDEN CL et al: A double-blind placebo-controlled prophylaxis study of lamotrigine in rapid cycling bipolar disorder. Clin. Psychiatr. (2000) 61:841–850.
   PubMed Web of Science ®Google Scholar
• KUSUMAKAR V, YATHAM L: 1518 Lamotrigine treatment of rapid cycling bipolar disorder. Am. Psychiatr. (1997) 154:1171–1172.
   PubMedGoogle Scholar
• ANGST J: The emerging epidemiology of hypomania and bipolar II disorder.' Affect. Diseirl (1998) 50:143–151.
   PubMed Web of Science ®Google Scholar
• BENAZZI F: Prevalence of bipolar II disorder in outpatient depression: A 203-case study in private practice. Affect. Diseirl (2002) 43:163–166.
   Google Scholar
• AKISKAL HS, MASER JD, ZELLER PJ, ENDIC OTT J, CORYELL W, KELLER M: Switching from 'unipolar' to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch. Gen. Psychiatr. (1995) 52:114–123.
   Google Scholar
• SUPPES T, BROWN ES, MCELROY SL et al.: Lamotrigine for the treatment of bipolar disorder: a clincial case series.Affect.Disc& (1999) 53:95–98.
   PubMed Web of Science ®Google Scholar
• HERTZBERG MA, BUTTERFIELD MI, FELDMAN ME et al.: A preliminary study of lamotrigine or the treatment of posttraumatic stress disorder. Biel Psychiatr. (1999) 45:1226–1229.
   PubMed Web of Science ®Google Scholar
• FOGELSON DL, STERNBACH H: Lamotrigine treatment of refractory bipolar disorder. .1 Cilia. Psychiatr. (1997) 58:271–273.
   PubMedGoogle Scholar
• WALDEN J, HESSLINGER B, VAN CALKER D, BERGER M: Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder. Pharmacepsychiatry (1996) 29:193–195.
   PubMed Web of Science ®Google Scholar
• TENNIS P: Nine-year interim results of thelamotrigine pregnancy registry. New research presentation. 155th American Psychiatric Association Annual Meeting. Philadelphia, PA, USA (18–23 May 2002).
   Google Scholar
• FATEMI SH, RAPPORT DJ, CALABRESE JR, THURAS P: Lamotrigine in rapid-cycling bipolar disorder. .1 Cilia. Psychiatr. (2002) 58:522–527.
   Google Scholar
• GLUE PW, NUTT DJ, COWEN PJ, BROADBENT D: Selective effect of lithium on cognitive performance in man. Psychepharmacelegia (1987) 91:109–111.
   PubMed Web of Science ®Google Scholar
• HIRSCHFELD RIVIA, BOWDEN CL, GITLIN MJ, KECK PE, SUPPES T, THASE ME: Practice guideline for the treatment of patients with bipolar disorder (revision). Am. J. Psychiatr. (2002) 159:1–50.
   Google Scholar